Trials / Conditions / Progression-free Survival

Progression-free Survival

27 registered clinical trials studyying Progression-free Survival — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer NCT06527001	Anhui Provincial Hospital	—
Recruiting	Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cance NCT06338683	Qinghai Red Cross Hospital	Phase 3
Recruiting	A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial NCT06215495	Zhujiang Hospital	N/A
Recruiting	Long-term Follow-up of Subjects Treated With CAR T Cells NCT05024175	Marcela V. Maus, M.D.,Ph.D.	—
Unknown	Advanced Pancreatic Cancer NCT05958849	Zhejiang Cancer Hospital	Phase 2
Unknown	Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanc NCT05897749	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	Phase 4
Recruiting	Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma. NCT05477797	RenJi Hospital	N/A
Recruiting	Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy NCT06826092	Kaohsiung Medical University Chung-Ho Memorial Hospital	Phase 2
Unknown	HRD and Resistance to PAPPi in EOC Patients NCT05310370	Lei Li	—
Unknown	Chromosomal Instability in Ovarian Cancer NCT05310357	Lei Li	—
Unknown	PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer NCT05310305	Lei Li	—
Recruiting	Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors NCT04933669	First Affiliated Hospital of Zhejiang University	Phase 2
Unknown	Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma NCT04664244	Lei Li	Phase 2
Not Yet Recruiting	Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total NCT04127760	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Unknown	Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Canc NCT04101760	Lei Li	Phase 3
Unknown	A Genomic Analysis of Evolution of Epithelia Ovarian Tumors NCT03742388	Lei Li	—
Unknown	IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative NCT03748680	Karen-Lise Garm Spindler	Phase 2
Completed	Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma NCT03359018	Peking University People's Hospital	Phase 2
Withdrawn	Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresecta NCT03342300	Peking University People's Hospital	Phase 2 / Phase 3
Unknown	Real-world Study for Patients With Advanced Hepatobiliary Tumors NCT03892577	Peking Union Medical College Hospital	—
Unknown	A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer NCT03100955	Qingdao University	Phase 3
Completed	Maintenance Therapy for Small-cell Lung Cancer NCT03769935	Qingdao Central Hospital	Phase 2
Unknown	Clinical Study on Triple Negative Breast Cancer With Chinese Medicine NCT03332368	Sheng Liu	—
Completed	Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer NCT02959749	Qingdao Central Hospital	Phase 2 / Phase 3
Completed	Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients NCT01453257	Grupo Hospital de Madrid	Phase 2
Completed	Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroida NCT00944918	AstraZeneca	Phase 3
Completed	Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma NCT05796700	Chinese PLA General Hospital	N/A